EDA Egypt

The Chairman of the Egyptian Drug Authority (EDA)Participates in the International Conference on Artificial Intelligence in Pharmaceutical Authorities in South Korea

The Egyptian Drug Authority (EDA) has officially announced its associate membership in the General European Official Medicines Control Laboratories Network (GEON), coordinated by the European Directorate for the Quality of Medicines & HealthCare (EDQM). This is a progressive step for the EDA to become one of the first leading regulatory bodies in the Arab world and Africa to receive this international recognition

the Egyptian Drug Authority (EDA) has signed a Memorandum of Understanding (MoU) with South Korea's Ministry of Food and Drug Safety.

As part of its commitment to expanding its international partnerships with major global pharmaceutical and regulatory institutions, the Egyptian Drug Authority (EDA) has signed a Memorandum of Understanding (MoU) with South Korea's Ministry of Food and Drug Safety.

The Egyptian Drug Authority Successfully Passes the EGAC Accreditation Follow-up for the Production of Reference Materials in Accordance with International Standard ISO 17034:2016

Chairman of the Egyptian Drug Authority (EDA) and His Pakistani Counterpart Discuss Prospects for Cooperation to Enhance Pharmaceutical Partnership.

Al-Ghamrawy: We are committed to supporting the global competitiveness of Egyptian pharmaceuticals and openness to international experiences.

Chairman of the Egyptian Drug Authority discusses with Health Flow and Fixed Egypt the mechanisms for implementing the digital prescription project to support healthcare services

El - Ghamrawy: The digital prescription is a strategic step towards achieving digital transformation in the healthcare sector. El - Ghamrawy: We aim to build an integrated pharmaceutical data system that supports the quality and efficiency of healthcare services.